1、Solae Confidential Three products categories of Clinical Nutrition Enteral Nutrition Enteral nutrition represents a provision of fulfilling the bodys nutritional requirements by using a tube into small intestine or stomach. Patients suffering from a disease or permanent non-function of structures, w 。

2、hich commonly allow supply of food to the small bowel, require enteral nutrition. Also, patients suffering from small bowel diseases that impair their oral diets digestion and absorption capability depend on enteral nutrition. Both require tube-based feedings to supply enough nutrients for maintaini 。

3、ng the patients strength and weight in proportion to overall health. Enteral nutrition is prescribed only when people are not able to intake food or optimum quantities of food due to illness. Enteral nutrition is applied only when a patients impairment is permanent. - Including pediatric and adult f 。

4、ormulas -Including oral supplements and tube supplements Parenteral Nutrition Parenteral nutrition is a specialized liquid food diet added to the blood via an intravenous catheter. Parenteral nutrition is described as the source of essential nutrients evading the digestive system. Such form of nutri 。

5、tion becomes important in situations where ingesting sufficient nutrients through the enteral/oral route is impossible. Parenteral nutrition is offered to children, infants, and adults. Additionally, the nutrition is supplied for a shorter duration and removed once the person begins normal eating. P 。

6、arenteral nutrition is the least favored choice because of the higher cost and the higher complication rate. - Including intravenously delivered formulas - Including infant, pediatric, and adult products Infant Nutrition Infants are required to intake other nourishing foods besides breast milk after 。

7、 5-6 months of birth. Infants experience fast growth as their bones, organs, facial features and joints are under formation. Poor nutrition leads to diseases, weakens the childs body, and also reduces beauty of facial features. Infant nutrition segment covers milk-based, soy-based, and special needs 。

8、 products. - Including infant formulas 0-12 months - Including follow-on formulas toddlers 12-36 months Solae Confidential Total Market Size and Forecast Solae Confidential Markets by Geographic Region- Global Clinical Nutrition In the global clinical nutrition market, six geographical markets are o 。

9、utlined in below Table: The world clinical nutrition products market is estimated at US$24.8 billion in 2010. The market is expected to grow further to reach US$34.5 billion in 2015, reflecting a CAGR of 8.6%. The US and European regions accounted for more than 60% of the total global clinical nutri 。

10、tion products market in 2009. However, the two markets are expected to lose share to China and rest of world gradually. Unlike European and the US markets, the Chinese market is expected to increase its share from 7.5% in 2009 to 10.5% in 2015. Further, the Chinese clinical nutrition products market 。

11、 is poised to register the fastest growth of about 14.1% over the period 2006-2015. World Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region US, Japan, Europe, China, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million。

12、for Years 2006 through 2015. 20062008 Solae Confidential Markets by Geographic Region- Global Clinical Nutrition World clinical nutrition products market accounted for US$ 21.9 billion in year 2008 with Nestle/Novartis as the leading player constituting a share of 18.5%. Abbott closely followed Nest 。

13、le and accounted for a share of 18.1%, while Fresenius Kabi bagged the third leading position with a share of 17.9% in 2008. The world clinical nutrition market is being fueled by two drivers that include market demographics and new product developments. The global clinical nutrition market is highl 。

14、y competitive and hosts few leading players that include Danone, Baxter International, Nestle, Mead Johnson, Abbott Laboratories, Wyeth, PBM Products, Fresenius Kabi, and B. Braun. Further, the competition is mainly due to the developed regions including the US, Western Europe, and Japan. Further, a 。

15、 number of players are extending presence across underdeveloped regions such as China and are increasingly offering competition to developed markets across the world. The introduction of new clinical nutrition products for paraenteral therapies is expected to replace older products. The clinical nut 。

16、rition industry is burgeoning on account of growth in the usage of homecare, which is fueling demand for easy to use products. Solae Confidential Industry snapshot Global clinical nutrition Leading Players in the Global Clinical Nutrition Market (2008): Percentage Breakdown of Value Sales for Nestle 。

17、/Novartis, Abbott, Fresenius Kabi, Numico/Danone, B. Braun, Baxter, and Others. (Source: GIA) Leading Suppliers Clinical Nutrition Revenues and Significant Segments of Participation, 2008 Solae Confidential 1.A Enteral Nutrition- General Enteral Nutrition for Patients aged 21 and older The patient n 。

18、eeds to be diagnosed with a barrier towards ingestion, absorption or digestion of daily food. The patient is also diagnosed of hepatic or renal failure. Standard products with 1-2 kcal/ml are prescribed if the product is the only source of patients nutrition. The elemental food products are included 。

19、 only on symptoms of mal-absorption conditions. The nutritionally incompetent or modular products are not included. The pregnant or lactating females entitled for the Special Supplemental Nutrition Program for WIC (women, infants, and children) need to obtain enteral products via WIC. Enteral Nutrit 。

20、ion for Patients Below 21 Years The commercial enteral food products are included only when such products account for 50% or more than 50% of the total calorie intake. The patients need to maintain a medical condition that limits the ability of ingesting, digesting, or absorbing daily food. The prod 。

21、ucts for in-born metabolism errors are covered along with records of suitable diagnosis. Elemental diets are prescribed only with records of a diagnosed mal-absorption condition. Modular products are recommended for conditions besides failure to thrive. Also, the requirement of 50% calories is not m 。

22、andatory for such products. Tube Feeding Nutrition supplied to individuals in forms other than normal intake from mouth is referred to as tube feeding. In tube feeding a specific liquid diet containing carbohydrates, proteins, mineral, vitamins, and fats is offered via a tube to the small intestine。

23、or stomach. Tube feeding is offered to people of various age groups, starting from infants to children and finally to adults. People survive quite well on tube feeding throughout the duration of its requirement. Tube feeding is deployed for shorter time intervals, with the tube being removed after t 。

24、he person starts eating normally again. Tube feeding is offered via various kinds of tubes and one tube is placed via the nose to the bowel or stomach. Such a tube is known as a nasoenteral or nasogastric feeding tube. In some instances, the tube is directly placed via the skin to the bowel or stoma 。

25、ch. Such a process is called jejunostomy or gastrostomy. Solae Confidential 1.B Global Market overview of Enteral Nutrition The enteral nutrition market including both oral and tube formulas is relatively stable with a large potential for growth. In 2008, sales for enteral nutrition products increas 。

26、ed 12.4% to $8.2 billion from $7.3 billion in 2007 and 12.3% over $6.5 billion in 2006. The market primarily consists of adult enteral formulas, while pediatric formulas contribute the remaining sales. Demand for enteral products remains steady in the United States and Japan while markets in Europe。

27、are increasing significantly. One factor driving growth is the increased use of enteral products in home care settings, which is continuing to grow worldwide. Another factor contributing to growth is the focus on providing nutrition on a disease-specific basis. Solae Confidential 1.1 Industry snapsh 。

28、ot Enteral Nutrition Leading Players in the Global Clinical Nutrition Market (2008): Percentage Breakdown of Value Sales for Nestle/Novartis, Abbott, Fresenius Kabi, Numico/ Danone, B. Braun, Baxter, and Others. World enteral nutrition market is highly consolidated with top three players accounting。

29、for more than 70% of the market. Abbott and Nestle bagged the leading positions and accounted for respective shares of 29.5% and 25.3% in year 2007. The enteral nutrition market is further segmented into enteral infant products and enteral adult products. The adult enteral formulations mainly includ 。

30、e whole or fractional ingredients including whole oils, fatty acids, phospholipids, whole proteins, peptides, and amino acids. The adult enteral formulations sector is a major market accounting for a share in the overall market. The major players in the adult nutrition market include GlaxoSmithKline 。

31、, Novartis, Nutritek, KAO, Otsuka Pharmaceuticals, Biersdoff, Nutricia, US Dentak, Elli Lilly, Pacific Health Pharmaceuticals, Fujisawa, Fresenius Kabi Enteral Nutrition, Warner Lambert, Merck & Co., and Gillette -Oral-B. While the enteral infant products market is governed by Mead Johnson, Wyeth, N 。

32、umico, and Nestle Clinical Nutrition. (Source: GIA) Solae Confidential 1.2 Global Market overview of Enteral Nutrition Solae Confidential 1.3 Global player and China presence of Enteral Nutrition Global: The enteral nutrition market is a currently stable, yet highly poised for strong growth potentia 。

33、l. Manufacturers in the enteral market include global leaders such as Abbott and Nestle, and regional leaders including Fresenius Kabi, Danone and Otsuka Pharmaceutical. A changing market place combined with changing demographics will provide new opportunities for manufacturers in the future. China: 。

34、 There remains a significant opportunity for enteral nutrition markets in China. Chinas health professionals still exhibit poor knowledge of the benefits of enteral nutrition versus standard external methods. Education is key to market growth for enteral nutrition in China. Currently the market is e 。

35、stimated at $496 million, with double- digit growth realized. The region has a potential of more than $1 billion with proper education of health professionals, government agencies, and the general public. Solae Confidential Application Overview Soy products in EN: Enteral Nutrition Formula Solae Con 。

36、fidential Enteral Nutrition 肠内营养肠内营养 产品用法： 1. Oral Feeding or RTD 经口直接食用或饮 用 2010 Solae, LLC. All rights reserved. 2. Tube-feeding 管饲 Solae Confidential Markets by Geographic Region- Global Clinical Nutrition World clinical nutrition products market accounted for US$ 21.9 billion in year 2008 with N 。

37、estle/Novartis as the leading player constituting a share of 18.5%. Abbott closely followed Nestle and accounted for a share of 18.1%, while Fresenius Kabi bagged the third leading position with a share of 17.9% in 2008. The world clinical nutrition market is being fueled by two drivers that include 。

38、 market demographics and new product developments. The global clinical nutrition market is highly competitive and hosts few leading players that include Danone, Baxter International, Nestle, Mead Johnson, Abbott Laboratories, Wyeth, PBM Products, Fresenius Kabi, and B. Braun. Further, the competitio 。

39、n is mainly due to the developed regions including the US, Western Europe, and Japan. Further, a number of players are extending presence across underdeveloped regions such as China and are increasingly offering competition to developed markets across the world. The introduction of new clinical nutr 。

40、ition products for paraenteral therapies is expected to replace older products. The clinical nutrition industry is burgeoning on account of growth in the usage of homecare, which is fueling demand for easy to use products. Solae Confidential 1.A Enteral Nutrition- General Enteral Nutrition for Patie 。

41、nts aged 21 and older The patient needs to be diagnosed with a barrier towards ingestion, absorption or digestion of daily food. The patient is also diagnosed of hepatic or renal failure. Standard products with 1-2 kcal/ml are prescribed if the product is the only source of patients nutrition. The e 。

42、lemental food products are included only on symptoms of mal-absorption conditions. The nutritionally incompetent or modular products are not included. The pregnant or lactating females entitled for the Special Supplemental Nutrition Program for WIC (women, infants, and children) need to obtain enter 。

43、al products via WIC. Enteral Nutrition for Patients Below 21 Years The commercial enteral food products are included only when such products account for 50% or more than 50% of the total calorie intake. The patients need to maintain a medical condition that limits the ability of ingesting, digesting 。

44、, or absorbing daily food. The products for in-born metabolism errors are covered along with records of suitable diagnosis. Elemental diets are prescribed only with records of a diagnosed mal-absorption condition. Modular products are recommended for conditions besides failure to thrive. Also, the r 。

45、equirement of 50% calories is not mandatory for such products. Tube Feeding Nutrition supplied to individuals in forms other than normal intake from mouth is referred to as tube feeding. In tube feeding a specific liquid diet containing carbohydrates, proteins, mineral, vitamins, and fats is offered 。

46、 via a tube to the small intestine or stomach. Tube feeding is offered to people of various age groups, starting from infants to children and finally to adults. People survive quite well on tube feeding throughout the duration of its requirement. Tube feeding is deployed for shorter time intervals,。

47、with the tube being removed after the person starts eating normally again. Tube feeding is offered via various kinds of tubes and one tube is placed via the nose to the bowel or stomach. Such a tube is known as a nasoenteral or nasogastric feeding tube. In some instances, the tube is directly placed 。

48、 via the skin to the bowel or stomach. Such a process is called jejunostomy or gastrostomy. Solae Confidential 1.1 Industry snapshot Enteral Nutrition Leading Players in the Global Clinical Nutrition Market (2008): Percentage Breakdown of Value Sales for Nestle/Novartis, Abbott, Fresenius Kabi, Numi 。

49、co/ Danone, B. Braun, Baxter, and Others. World enteral nutrition market is highly consolidated with top three players accounting for more than 70% of the market. Abbott and Nestle bagged the leading positions and accounted for respective shares of 29.5% and 25.3% in year 2007. The enteral nutrition 。

50、 market is further segmented into enteral infant products and enteral adult products. The adult enteral formulations mainly include whole or fractional ingredients including whole oils, fatty acids, phospholipids, whole proteins, peptides, and amino acids. The adult enteral formulations sector is a。

【全球|全球临床营养概况英文】51、major market accounting for a share in the overall market. The major players in the adult nutrition market include GlaxoSmithKline, Novartis, Nutritek, KAO, Otsuka Pharmaceuticals, Biersdoff, Nutricia, US Dentak, Elli Lilly, Pacific Health Pharmaceuticals, Fujisawa, Fresenius Kabi Enteral Nutrition, Warner Lambert, Merck & Co., and Gillette -Oral-B. While the enteral infant products market is governed by Mead Johnson, Wyeth, Numico, and Nestle Clinical Nutrition. (Source: GIA) 。

稿源：(未知)

【傻大方】网址：/a/2021/0526/0022272466.html

标题：全球|全球临床营养概况英文